Three hundred and fifty-one patients ( aged 12years ; uncontrolled by non-ICS therapy ) were randomized to treatment ( 1:1:1 ) with once-daily FF50mcg dosed in the evening , twice-daily fluticasone propionate ( FP ) 100mcg or placebo .